SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004605
Filing Date
2021-11-15
Accepted
2021-11-15 16:21:00
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20210930.htm   iXBRL 10-Q 3485631
2 EX-31.1 mirm-ex31_1.htm EX-31.1 19700
3 EX-31.2 mirm-ex31_2.htm EX-31.2 19836
4 EX-32.1 mirm-ex32_1.htm EX-32.1 11152
5 EX-32.2 mirm-ex32_2.htm EX-32.2 11285
  Complete submission text file 0000950170-21-004605.txt   10843964

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20210930_cal.xml EX-101.CAL 48557
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20210930_def.xml EX-101.DEF 276182
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20210930.xsd EX-101.SCH 68779
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20210930_lab.xml EX-101.LAB 540102
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20210930_pre.xml EX-101.PRE 415290
11 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20210930_htm.xml XML 1936657
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 211411016
SIC: 2834 Pharmaceutical Preparations